To ensure timely access to life-saving orphan drugs for patients, the government has exempted mandatory sampling and testing at port offices. The drug regulator will now release consignments based on a legal undertaking from the importer. This decision addresses challenges like small volumes and specialized testing needs, streamlining the process and preventing delays in crucial treatments.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ml7zacb
via IFTTT
No comments:
Post a Comment